nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—Dizziness—Mitomycin—stomach cancer	0.00431	0.00434	CcSEcCtD
Cefadroxil—Hepatic failure—Capecitabine—stomach cancer	0.00429	0.00432	CcSEcCtD
Cefadroxil—Haemolytic anaemia—Capecitabine—stomach cancer	0.00427	0.0043	CcSEcCtD
Cefadroxil—Vomiting—Mitomycin—stomach cancer	0.00414	0.00418	CcSEcCtD
Cefadroxil—Rash—Mitomycin—stomach cancer	0.00411	0.00414	CcSEcCtD
Cefadroxil—Dermatitis—Mitomycin—stomach cancer	0.0041	0.00414	CcSEcCtD
Cefadroxil—Headache—Mitomycin—stomach cancer	0.00408	0.00412	CcSEcCtD
Cefadroxil—Haemoglobin—Irinotecan—stomach cancer	0.004	0.00404	CcSEcCtD
Cefadroxil—Haemorrhage—Irinotecan—stomach cancer	0.00398	0.00402	CcSEcCtD
Cefadroxil—Agranulocytosis—Fluorouracil—stomach cancer	0.00397	0.004	CcSEcCtD
Cefadroxil—Vaginal inflammation—Methotrexate—stomach cancer	0.00395	0.00398	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—stomach cancer	0.00391	0.00394	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—stomach cancer	0.00388	0.00392	CcSEcCtD
Cefadroxil—Nausea—Mitomycin—stomach cancer	0.00387	0.0039	CcSEcCtD
Cefadroxil—Haemoglobin—Fluorouracil—stomach cancer	0.00383	0.00387	CcSEcCtD
Cefadroxil—Haemorrhage—Fluorouracil—stomach cancer	0.00381	0.00385	CcSEcCtD
Cefadroxil—Vaginal infection—Methotrexate—stomach cancer	0.00373	0.00376	CcSEcCtD
Cefadroxil—Aplastic anaemia—Methotrexate—stomach cancer	0.00371	0.00374	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—stomach cancer	0.0037	0.00373	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—stomach cancer	0.0037	0.00373	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—stomach cancer	0.00362	0.00365	CcSEcCtD
Cefadroxil—Blood creatinine increased—Capecitabine—stomach cancer	0.00361	0.00364	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—stomach cancer	0.00359	0.00362	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.00358	0.00361	CcSEcCtD
Cefadroxil—Cramp muscle—Docetaxel—stomach cancer	0.00358	0.00361	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.00358	0.00361	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.00351	0.00354	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—stomach cancer	0.00349	0.00352	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—stomach cancer	0.00349	0.00352	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—stomach cancer	0.00347	0.0035	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.00347	0.0035	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.00347	0.0035	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—stomach cancer	0.00342	0.00345	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—stomach cancer	0.00342	0.00345	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.0034	0.00343	CcSEcCtD
Cefadroxil—Muscle spasms—Irinotecan—stomach cancer	0.00333	0.00336	CcSEcCtD
Cefadroxil—Pancytopenia—Docetaxel—stomach cancer	0.00327	0.00329	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—stomach cancer	0.00323	0.00326	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—stomach cancer	0.00323	0.00326	CcSEcCtD
Cefadroxil—Neutropenia—Docetaxel—stomach cancer	0.00322	0.00324	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—stomach cancer	0.00321	0.00324	CcSEcCtD
Cefadroxil—Hepatic failure—Methotrexate—stomach cancer	0.00319	0.00322	CcSEcCtD
Cefadroxil—Pancytopenia—Capecitabine—stomach cancer	0.00316	0.00319	CcSEcCtD
Cefadroxil—Vertigo—Irinotecan—stomach cancer	0.00312	0.00314	CcSEcCtD
Cefadroxil—Neutropenia—Capecitabine—stomach cancer	0.00311	0.00314	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.00309	0.00311	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—stomach cancer	0.00307	0.0031	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.00304	0.00307	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—stomach cancer	0.00299	0.00301	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.00294	0.00297	CcSEcCtD
Cefadroxil—Convulsion—Fluorouracil—stomach cancer	0.00288	0.0029	CcSEcCtD
Cefadroxil—Agranulocytosis—Docetaxel—stomach cancer	0.00286	0.00289	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.00286	0.00288	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00284	0.00287	CcSEcCtD
Cefadroxil—Anaphylactic shock—Irinotecan—stomach cancer	0.00283	0.00285	CcSEcCtD
Cefadroxil—Agranulocytosis—Capecitabine—stomach cancer	0.00277	0.00279	CcSEcCtD
Cefadroxil—Thrombocytopenia—Irinotecan—stomach cancer	0.00277	0.00279	CcSEcCtD
Cefadroxil—Haemoglobin—Docetaxel—stomach cancer	0.00277	0.00279	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—stomach cancer	0.00276	0.00279	CcSEcCtD
Cefadroxil—Haemorrhage—Docetaxel—stomach cancer	0.00275	0.00278	CcSEcCtD
Cefadroxil—Anaphylactic shock—Fluorouracil—stomach cancer	0.00271	0.00273	CcSEcCtD
Cefadroxil—Haemoglobin—Capecitabine—stomach cancer	0.00268	0.0027	CcSEcCtD
Cefadroxil—Haemorrhage—Capecitabine—stomach cancer	0.00267	0.00269	CcSEcCtD
Cefadroxil—Thrombocytopenia—Fluorouracil—stomach cancer	0.00265	0.00268	CcSEcCtD
Cefadroxil—Erythema multiforme—Docetaxel—stomach cancer	0.0026	0.00262	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.00258	0.0026	CcSEcCtD
Cefadroxil—Erythema multiforme—Capecitabine—stomach cancer	0.00252	0.00254	CcSEcCtD
Cefadroxil—Somnolence—Irinotecan—stomach cancer	0.00252	0.00254	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—stomach cancer	0.00251	0.00254	CcSEcCtD
Cefadroxil—Dyspepsia—Irinotecan—stomach cancer	0.00249	0.00251	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00247	0.00249	CcSEcCtD
Cefadroxil—Eosinophilia—Methotrexate—stomach cancer	0.00245	0.00247	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00244	0.00246	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.00242	0.00244	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.00242	0.00244	CcSEcCtD
Cefadroxil—Somnolence—Fluorouracil—stomach cancer	0.00241	0.00243	CcSEcCtD
Cefadroxil—Dyspepsia—Fluorouracil—stomach cancer	0.00239	0.00241	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.00237	0.00239	CcSEcCtD
Cefadroxil—Pancytopenia—Methotrexate—stomach cancer	0.00235	0.00237	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00234	0.00236	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—stomach cancer	0.00233	0.00235	CcSEcCtD
Cefadroxil—Neutropenia—Methotrexate—stomach cancer	0.00232	0.00234	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Irinotecan—stomach cancer	0.00231	0.00233	CcSEcCtD
Cefadroxil—Muscle spasms—Docetaxel—stomach cancer	0.0023	0.00232	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—stomach cancer	0.0023	0.00232	CcSEcCtD
Cefadroxil—Abdominal pain—Irinotecan—stomach cancer	0.00224	0.00226	CcSEcCtD
Cefadroxil—Body temperature increased—Irinotecan—stomach cancer	0.00224	0.00226	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00224	0.00226	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.00224	0.00226	CcSEcCtD
Cefadroxil—Muscle spasms—Capecitabine—stomach cancer	0.00223	0.00225	CcSEcCtD
Cefadroxil—Drowsiness—Methotrexate—stomach cancer	0.00221	0.00223	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—stomach cancer	0.0022	0.00222	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00219	0.00221	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.00219	0.00221	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—stomach cancer	0.00217	0.00219	CcSEcCtD
Cefadroxil—Urticaria—Fluorouracil—stomach cancer	0.00215	0.00217	CcSEcCtD
Cefadroxil—Body temperature increased—Fluorouracil—stomach cancer	0.00214	0.00216	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—stomach cancer	0.00213	0.00214	CcSEcCtD
Cefadroxil—Vertigo—Capecitabine—stomach cancer	0.00208	0.0021	CcSEcCtD
Cefadroxil—Hypersensitivity—Irinotecan—stomach cancer	0.00208	0.0021	CcSEcCtD
Cefadroxil—Convulsion—Docetaxel—stomach cancer	0.00208	0.00209	CcSEcCtD
Cefadroxil—Cefpiramide—ALB—stomach cancer	0.00207	0.256	CrCbGaD
Cefadroxil—Drowsiness—Epirubicin—stomach cancer	0.00207	0.00209	CcSEcCtD
Cefadroxil—Agranulocytosis—Methotrexate—stomach cancer	0.00206	0.00208	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00205	0.00207	CcSEcCtD
Cefadroxil—Arthralgia—Docetaxel—stomach cancer	0.00204	0.00206	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—stomach cancer	0.00204	0.00206	CcSEcCtD
Cefadroxil—Asthenia—Irinotecan—stomach cancer	0.00203	0.00205	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—stomach cancer	0.00201	0.00202	CcSEcCtD
Cefadroxil—Hypersensitivity—Fluorouracil—stomach cancer	0.002	0.00201	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—stomach cancer	0.00199	0.00201	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—stomach cancer	0.00198	0.002	CcSEcCtD
Cefadroxil—Arthralgia—Capecitabine—stomach cancer	0.00198	0.00199	CcSEcCtD
Cefadroxil—Anaphylactic shock—Docetaxel—stomach cancer	0.00196	0.00197	CcSEcCtD
Cefadroxil—Diarrhoea—Irinotecan—stomach cancer	0.00194	0.00195	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—stomach cancer	0.00193	0.00195	CcSEcCtD
Cefadroxil—Pruritus—Fluorouracil—stomach cancer	0.00192	0.00193	CcSEcCtD
Cefadroxil—Thrombocytopenia—Docetaxel—stomach cancer	0.00192	0.00193	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—stomach cancer	0.00191	0.00193	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.0019	0.00191	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—stomach cancer	0.00188	0.00189	CcSEcCtD
Cefadroxil—Dizziness—Irinotecan—stomach cancer	0.00187	0.00189	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—stomach cancer	0.00187	0.00188	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—stomach cancer	0.00186	0.00187	CcSEcCtD
Cefadroxil—Diarrhoea—Fluorouracil—stomach cancer	0.00185	0.00187	CcSEcCtD
Cefadroxil—Thrombocytopenia—Capecitabine—stomach cancer	0.00185	0.00187	CcSEcCtD
Cefadroxil—Cefonicid—ALB—stomach cancer	0.00181	0.223	CrCbGaD
Cefadroxil—Vomiting—Irinotecan—stomach cancer	0.0018	0.00181	CcSEcCtD
Cefadroxil—Dizziness—Fluorouracil—stomach cancer	0.00179	0.00181	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—stomach cancer	0.00179	0.0018	CcSEcCtD
Cefadroxil—Rash—Irinotecan—stomach cancer	0.00178	0.0018	CcSEcCtD
Cefadroxil—Dermatitis—Irinotecan—stomach cancer	0.00178	0.0018	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00178	0.0018	CcSEcCtD
Cefadroxil—Headache—Irinotecan—stomach cancer	0.00177	0.00179	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—stomach cancer	0.00176	0.00177	CcSEcCtD
Cefadroxil—Somnolence—Docetaxel—stomach cancer	0.00174	0.00175	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—stomach cancer	0.00173	0.00174	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00173	0.00174	CcSEcCtD
Cefadroxil—Vomiting—Fluorouracil—stomach cancer	0.00172	0.00174	CcSEcCtD
Cefadroxil—Dyspepsia—Docetaxel—stomach cancer	0.00172	0.00174	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—stomach cancer	0.00172	0.00173	CcSEcCtD
Cefadroxil—Rash—Fluorouracil—stomach cancer	0.00171	0.00172	CcSEcCtD
Cefadroxil—Dermatitis—Fluorouracil—stomach cancer	0.00171	0.00172	CcSEcCtD
Cefadroxil—Headache—Fluorouracil—stomach cancer	0.0017	0.00171	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00169	0.0017	CcSEcCtD
Cefadroxil—Nausea—Irinotecan—stomach cancer	0.00168	0.00169	CcSEcCtD
Cefadroxil—Dyspepsia—Capecitabine—stomach cancer	0.00167	0.00168	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00164	0.00165	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—stomach cancer	0.00162	0.00164	CcSEcCtD
Cefadroxil—Nausea—Fluorouracil—stomach cancer	0.00161	0.00162	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Docetaxel—stomach cancer	0.0016	0.00161	CcSEcCtD
Cefadroxil—Tension—Epirubicin—stomach cancer	0.00159	0.0016	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—stomach cancer	0.00157	0.00158	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—stomach cancer	0.00155	0.00157	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—stomach cancer	0.00155	0.00156	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Capecitabine—stomach cancer	0.00155	0.00156	CcSEcCtD
Cefadroxil—Body temperature increased—Docetaxel—stomach cancer	0.00155	0.00156	CcSEcCtD
Cefadroxil—Abdominal pain—Docetaxel—stomach cancer	0.00155	0.00156	CcSEcCtD
Cefadroxil—Urticaria—Capecitabine—stomach cancer	0.0015	0.00152	CcSEcCtD
Cefadroxil—Body temperature increased—Capecitabine—stomach cancer	0.0015	0.00151	CcSEcCtD
Cefadroxil—Abdominal pain—Capecitabine—stomach cancer	0.0015	0.00151	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—stomach cancer	0.0015	0.00151	CcSEcCtD
Cefadroxil—Arthralgia—Methotrexate—stomach cancer	0.00147	0.00148	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—stomach cancer	0.00147	0.00148	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—stomach cancer	0.00145	0.00146	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—stomach cancer	0.00145	0.00146	CcSEcCtD
Cefadroxil—Hypersensitivity—Docetaxel—stomach cancer	0.00144	0.00145	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—stomach cancer	0.00144	0.00145	CcSEcCtD
Cefadroxil—Anaphylactic shock—Methotrexate—stomach cancer	0.00141	0.00142	CcSEcCtD
Cefadroxil—Asthenia—Docetaxel—stomach cancer	0.0014	0.00141	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—stomach cancer	0.0014	0.00141	CcSEcCtD
Cefadroxil—Hypersensitivity—Capecitabine—stomach cancer	0.0014	0.00141	CcSEcCtD
Cefadroxil—Pruritus—Docetaxel—stomach cancer	0.00138	0.0014	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—stomach cancer	0.00138	0.00139	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—stomach cancer	0.00138	0.00139	CcSEcCtD
Cefadroxil—Asthenia—Capecitabine—stomach cancer	0.00136	0.00137	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—stomach cancer	0.00134	0.00135	CcSEcCtD
Cefadroxil—Pruritus—Capecitabine—stomach cancer	0.00134	0.00135	CcSEcCtD
Cefadroxil—Diarrhoea—Docetaxel—stomach cancer	0.00134	0.00135	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—stomach cancer	0.00132	0.00133	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—stomach cancer	0.0013	0.00131	CcSEcCtD
Cefadroxil—Diarrhoea—Capecitabine—stomach cancer	0.0013	0.00131	CcSEcCtD
Cefadroxil—Dizziness—Docetaxel—stomach cancer	0.00129	0.0013	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—stomach cancer	0.00129	0.0013	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00128	0.0013	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—stomach cancer	0.00127	0.00128	CcSEcCtD
Cefadroxil—Somnolence—Methotrexate—stomach cancer	0.00125	0.00126	CcSEcCtD
Cefadroxil—Dizziness—Capecitabine—stomach cancer	0.00125	0.00126	CcSEcCtD
Cefadroxil—Vomiting—Docetaxel—stomach cancer	0.00124	0.00125	CcSEcCtD
Cefadroxil—Dyspepsia—Methotrexate—stomach cancer	0.00124	0.00125	CcSEcCtD
Cefadroxil—Rash—Docetaxel—stomach cancer	0.00123	0.00124	CcSEcCtD
Cefadroxil—Dermatitis—Docetaxel—stomach cancer	0.00123	0.00124	CcSEcCtD
Cefadroxil—Headache—Docetaxel—stomach cancer	0.00123	0.00124	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—stomach cancer	0.00122	0.00123	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00122	0.00123	CcSEcCtD
Cefadroxil—Vomiting—Capecitabine—stomach cancer	0.0012	0.00121	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.0012	0.00121	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—stomach cancer	0.0012	0.00121	CcSEcCtD
Cefadroxil—Rash—Capecitabine—stomach cancer	0.00119	0.0012	CcSEcCtD
Cefadroxil—Dermatitis—Capecitabine—stomach cancer	0.00119	0.0012	CcSEcCtD
Cefadroxil—Headache—Capecitabine—stomach cancer	0.00119	0.0012	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—stomach cancer	0.00117	0.00118	CcSEcCtD
Cefadroxil—Nausea—Docetaxel—stomach cancer	0.00116	0.00117	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—stomach cancer	0.00116	0.00117	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Methotrexate—stomach cancer	0.00115	0.00116	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00114	0.00115	CcSEcCtD
Cefadroxil—Nausea—Capecitabine—stomach cancer	0.00112	0.00113	CcSEcCtD
Cefadroxil—Urticaria—Methotrexate—stomach cancer	0.00112	0.00113	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—stomach cancer	0.00111	0.00112	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—stomach cancer	0.00111	0.00112	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00111	0.00112	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—stomach cancer	0.00108	0.00109	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—stomach cancer	0.00107	0.00108	CcSEcCtD
Cefadroxil—Cefoperazone—ALB—stomach cancer	0.00106	0.131	CrCbGaD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00105	0.00106	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—stomach cancer	0.00105	0.00106	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—stomach cancer	0.00104	0.00105	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—stomach cancer	0.00104	0.00105	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—stomach cancer	0.00104	0.00105	CcSEcCtD
Cefadroxil—Asthenia—Methotrexate—stomach cancer	0.00101	0.00102	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000998	0.00101	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—stomach cancer	0.000997	0.00101	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—stomach cancer	0.000972	0.00098	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—stomach cancer	0.00097	0.000978	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—stomach cancer	0.000965	0.000973	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—stomach cancer	0.000965	0.000973	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—stomach cancer	0.000965	0.000973	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—stomach cancer	0.000947	0.000954	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—stomach cancer	0.000933	0.000941	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—stomach cancer	0.000932	0.00094	CcSEcCtD
Cefadroxil—Ampicillin—ALB—stomach cancer	0.000905	0.112	CrCbGaD
Cefadroxil—Diarrhoea—Epirubicin—stomach cancer	0.000903	0.00091	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—stomach cancer	0.000899	0.000907	CcSEcCtD
Cefadroxil—Vomiting—Methotrexate—stomach cancer	0.000896	0.000904	CcSEcCtD
Cefadroxil—Rash—Methotrexate—stomach cancer	0.000889	0.000896	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—stomach cancer	0.000888	0.000895	CcSEcCtD
Cefadroxil—Headache—Methotrexate—stomach cancer	0.000883	0.00089	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—stomach cancer	0.000876	0.000883	CcSEcCtD
Cefadroxil—Cefazolin—ALB—stomach cancer	0.000875	0.108	CrCbGaD
Cefadroxil—Dizziness—Epirubicin—stomach cancer	0.000872	0.00088	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—stomach cancer	0.000864	0.000871	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—stomach cancer	0.000839	0.000846	CcSEcCtD
Cefadroxil—Nausea—Methotrexate—stomach cancer	0.000837	0.000844	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—stomach cancer	0.000835	0.000842	CcSEcCtD
Cefadroxil—Rash—Epirubicin—stomach cancer	0.000832	0.000839	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—stomach cancer	0.000831	0.000838	CcSEcCtD
Cefadroxil—Headache—Epirubicin—stomach cancer	0.000827	0.000833	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—stomach cancer	0.000807	0.000814	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—stomach cancer	0.000784	0.00079	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—stomach cancer	0.000776	0.000783	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—stomach cancer	0.00077	0.000776	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—stomach cancer	0.000769	0.000775	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—stomach cancer	0.000765	0.000771	CcSEcCtD
Cefadroxil—Cefalotin—ALB—stomach cancer	0.000727	0.0896	CrCbGaD
Cefadroxil—Nausea—Doxorubicin—stomach cancer	0.000725	0.000731	CcSEcCtD
Cefadroxil—Cephalexin—ALB—stomach cancer	0.00066	0.0814	CrCbGaD
